Factor XII deficiency, also known as the Hageman factor, is a rare disorder that has not been associated with any adverse outcomes. It is an interesting blood disorder whereby in the state of deficiency, it causes prolongation activated partial thromboplastin time (aPTT) which is correctable with mixing test. Although there have been case reports that have mentioned events of thrombosis and bleeding, however, no clear causal relationship has been established. Evidence for adverse events occurring in patients with Factor XII deficiency is sparse. We report here a case of a lady with a history of miscarriages who was incidentally found to have Factor XII deficiency during a routine workup for prolonged aPTT
A 21-year-old man with mandibular prognathism was referred to Tokyo Medical University Hospital. The...
Factor XI deficiency (FXI) is the third most common coagulation factor deficiency after hemophilia A...
Essentials Inherited factor XIII deficiency is a very rare bleeding disorder. We used recombinant fa...
Tow cases with congenital F.XII deficiency from tow families were reported. A 64-yers-old female (ca...
Objective. To evaluate factor XII levels in women with recurrent pregnancy loss (RPL) in a tertiary ...
Severe coagulation factor XII (FXII) deficiency is a very rare, mysterious, and not well-known inher...
Abstract Background Antiphospholipid syndrome (APS) has been often associated to RPL since 1980 and ...
Factor XII (FXII) deficiency is a congenital disorder inherited as an autosomal recessive condition....
Twelve women with severe Factor XII (FXII) deficiency were under observation for an average period o...
According to our personal experience and to the study of the literature, 11 cases of venous thrombos...
We report on a 57-year-old woman with a pontine haemorrhage and an extremely prolonged activated par...
WOS: 000385272300025Factor XII deficiency is an important hematological problem which is characteriz...
Factor XII deficiency is an important hematological problem which is characterized by isolated prolo...
We describe here the case of a 46-year-old man admitted to the emergency department (ED) and diagnos...
Introduction Defects in the coagulation pathway involving Factor XII (Hageman factor) causes laborat...
A 21-year-old man with mandibular prognathism was referred to Tokyo Medical University Hospital. The...
Factor XI deficiency (FXI) is the third most common coagulation factor deficiency after hemophilia A...
Essentials Inherited factor XIII deficiency is a very rare bleeding disorder. We used recombinant fa...
Tow cases with congenital F.XII deficiency from tow families were reported. A 64-yers-old female (ca...
Objective. To evaluate factor XII levels in women with recurrent pregnancy loss (RPL) in a tertiary ...
Severe coagulation factor XII (FXII) deficiency is a very rare, mysterious, and not well-known inher...
Abstract Background Antiphospholipid syndrome (APS) has been often associated to RPL since 1980 and ...
Factor XII (FXII) deficiency is a congenital disorder inherited as an autosomal recessive condition....
Twelve women with severe Factor XII (FXII) deficiency were under observation for an average period o...
According to our personal experience and to the study of the literature, 11 cases of venous thrombos...
We report on a 57-year-old woman with a pontine haemorrhage and an extremely prolonged activated par...
WOS: 000385272300025Factor XII deficiency is an important hematological problem which is characteriz...
Factor XII deficiency is an important hematological problem which is characterized by isolated prolo...
We describe here the case of a 46-year-old man admitted to the emergency department (ED) and diagnos...
Introduction Defects in the coagulation pathway involving Factor XII (Hageman factor) causes laborat...
A 21-year-old man with mandibular prognathism was referred to Tokyo Medical University Hospital. The...
Factor XI deficiency (FXI) is the third most common coagulation factor deficiency after hemophilia A...
Essentials Inherited factor XIII deficiency is a very rare bleeding disorder. We used recombinant fa...